TIDMHIK

RNS Number : 2787S

Hikma Pharmaceuticals Plc

15 March 2021

Hikma Pharmaceuticals PLC - EIP B Vesting

LONDON, 15 March 2021: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards which were granted on 12 March 2019 under the 2014 Executive Incentive Plan ("EIP") Element B.

Notification and public disclosure of transactions by persons discharging managerial responsibilities

Said Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Said Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Shares acquired from the vesting of conditional 
       transaction               awards on 
                                 12 March 2021 under the EIP Element B. All 
                                 Shares were retained. 
 c)   Price(s) and              Price(s): GBPnil 
       volume(s)                 Volume(s): 61,666 
 d)   Aggregated information 
        *    Volume 
                                 61,666 
                                 GBP0.00 
        *    Price               GBP0.00 
 
 
        *    Total 
 e)   Date of the transaction   12 March 2021 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Siggi Olafsson

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Sigurdur Olafsson 
 2    Reason for the notification 
 a)   Position/status           Chief Executive Officer 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Shares acquired from the vesting of conditional 
       transaction               awards on 
                                 12 March 2021 under the EIP Element B. Shares 
                                 were sold to cover tax and the remainder were 
                                 retained. 
 c)   Price(s) and              Price(s): GBPnil 
       volume(s)                 Volume(s): 35,513 
 
                                 Price(s): GBP22.057 
                                 Volume(s): 31,794 
 d)   Aggregated information 
        *    Volume 
                                 67,307 
                                 GBP22.057 
        *    Price               GBP701,280.26 
 
 
        *    Total 
 e)   Date of the transaction  12 March 2021 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Mazen Darwazah

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Mazen Darwazah 
 2    Reason for the notification 
 a)   Position/status           Executive Vice Chairman 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Shares acquired from the vesting of conditional 
       transaction               awards on 
                                 12 March 2021 under the EIP Element B. All 
                                 Shares were retained. 
 c)   Price(s) and              Price(s): GBPnil 
       volume(s)                 Volume(s): 42,572 
 d)   Aggregated information 
        *    Volume 
                                 42,572 
                                 GBP0.00 
        *    Price               GBP0.00 
 
 
        *    Total 
 e)   Date of the transaction   12 March 2021 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Riad Mishlawi

 
1   Details of the person discharging managerial responsibilities 
     / person closely associated 
a)  Name                     Riad Mishlawi 
2   Reason for the notification 
a)  Position/status          PDMR 
b)  Initial notification     Initial notification 
     /Amendment 
3   Details of the issuer, emission allowance market participant, 
     auction platform, auctioneer or auction monitor 
a)  Name                     Hikma Pharmaceuticals PLC 
b)  LEI                      549300BNS685UXH4JI75 
4   Details of the transaction(s): section to be repeated for 
     (i) each type of instrument; (ii) each type of transaction; 
     (iii) each date; and (iv) each place where transactions have 
     been conducted 
a)  Description of           Description: Ordinary shares of 10 pence each 
     the financial            (Shares) 
     instrument, type         ID Code: GB00B0LCW083 
     of instrument 
     and identification 
     code 
b)  Nature of the            Shares acquired from the vesting of conditional 
     transaction              awards on 
                              12 March 2021 under the EIP Element B. All 
                              Shares were retained. 
c)  Price(s) and             Price(s): GBPnil 
     volume(s)                Volume(s): 32,027 
d)   Aggregated information 
       *    Volume 
                               32,027 
                               GBP0.00 
       *    Price              GBP0.00 
 
 
       *    Total 
e)  Date of the transaction  12 March 2021 
f)  Place of the             London Stock Exchange (XLON) 
     transaction 
 

Majda Labadi

 
1   Details of the person discharging managerial responsibilities 
     / person closely associated 
a)  Name                     Majda Labadi 
2   Reason for the notification 
a)  Position/status          PDMR 
b)  Initial notification     Initial notification 
     /Amendment 
3   Details of the issuer, emission allowance market participant, 
     auction platform, auctioneer or auction monitor 
a)  Name                     Hikma Pharmaceuticals PLC 
b)  LEI                      549300BNS685UXH4JI75 
4   Details of the transaction(s): section to be repeated for 
     (i) each type of instrument; (ii) each type of transaction; 
     (iii) each date; and (iv) each place where transactions have 
     been conducted 
a)  Description of           Description: Ordinary shares of 10 pence each 
     the financial            (Shares) 
     instrument, type         ID Code: GB00B0LCW083 
     of instrument 
     and identification 
     code 
b)  Nature of the            Shares acquired from the vesting of conditional 
     transaction              awards on 
                              12 March 2021 under the EIP Element B. All 
                              Shares were retained. 
c)  Price(s) and             Price(s): GBPnil 
     volume(s)                Volume(s): 17,091 
d)   Aggregated information 
       *    Volume 
                               17,091 
                               GBP0.00 
       *    Price              GBP0.00 
 
 
       *    Total 
e)  Date of the transaction  12 March 2021 
f)  Place of the             London Stock Exchange (XLON) 
     transaction 
 

Bassam Kanaan

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Bassam Kanaan 
 2    Reason for the notification 
 a)   Position/status           PDMR 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the            Shares acquired from the vesting of conditional 
       transaction              awards on 
                                12 March 2021 under the EIP Element B. All 
                                Shares were retained. 
 c)   Price(s) and              Price(s): GBPnil 
       volume(s)                 Volume(s): 27,193 
 d)   Aggregated information 
        *    Volume 
                                 27,193 
                                 GBP0.00 
        *    Price               GBP0.00 
 
 
        *    Total 
 e)   Date of the transaction  12 March 2021 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Khalid Nabilsi

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Khalid Nabilsi 
 2    Reason for the notification 
 a)   Position/status           PDMR 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Shares acquired from the vesting of conditional 
       transaction               awards on 
                                 12 March 2021 under the EIP Element B. All 
                                 Shares were retained. 
 c)   Price(s) and              Price(s): GBPnil 
       volume(s)                 Volume(s): 25,089 
 d)   Aggregated information 
        *    Volume 
                                 25,089 
                                 GBP0.00 
        *    Price               GBP0.00 
 
 
        *    Total 
 e)   Date of the transaction   12 March 2021 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Brian Hoffmann

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Brian Hoffmann 
 2    Reason for the notification 
 a)   Position/status           PDMR 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Shares acquired from the vesting of conditional 
       transaction               awards on 
                                 12 March 2021 under the EIP Element B. Shares 
                                 were sold to cover tax and the remainder were 
                                 retained. 
 c)   Price(s) and              Price(s): GBPnil 
       volume(s)                 Volume(s): 8,435 
 
                                 Price(s): GBP22.057 
                                 Volume(s): 7,552 
 d)   Aggregated information 
        *    Volume 
                                 15,987 
                                 GBP22.057 
        *    Price               GBP166,574.46 
 
 
        *    Total 
 e)   Date of the transaction   12 March 2021 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Susan Ringdal

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Susan Ringdal 
 2    Reason for the notification 
 a)   Position/status           PDMR 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Shares acquired from the vesting of conditional 
       transaction               awards on 
                                 12 March 2021 under the EIP Element B. Shares 
                                 were sold to cover tax and the remainder were 
                                 retained. 
 c)   Price(s) and              Price(s): GBPnil 
       volume(s)                 Volume(s): 7,626 
 
                                 Price(s): GBP22.057 
                                 Volume(s): 6,828 
 d)   Aggregated information 
        *    Volume 
                                 14,454 
                                 GBP22.057 
        *    Price               GBP150,605.20 
 
 
        *    Total 
 e)   Date of the transaction   12 March 2021 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Henriette Nielsen

 
 1    Details of the person discharging managerial responsibilities 
       / person closely associated 
 a)   Name                      Henriette Nielsen 
 2    Reason for the notification 
 a)   Position/status           PDMR 
 b)   Initial notification      Initial notification 
       /Amendment 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
 a)   Name                      Hikma Pharmaceuticals PLC 
 b)   LEI                       549300BNS685UXH4JI75 
 4    Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
 a)   Description of            Description: Ordinary shares of 10 pence each 
       the financial             (Shares) 
       instrument, type          ID Code: GB00B0LCW083 
       of instrument 
       and identification 
       code 
 b)   Nature of the             Shares acquired from the vesting of conditional 
       transaction               awards on 
                                 12 March 2021 under the EIP Element B. Shares 
                                 were sold to cover tax and the remainder were 
                                 retained. 
 c)   Price(s) and              Price(s): GBPnil 
       volume(s)                 Volume(s): 4,627 
 
                                 Price(s): GBP22.057 
                                 Volume(s): 5,275 
 d)   Aggregated information 
        *    Volume 
                                 9,902 
                                 GBP22.057 
        *    Price               GBP116,350.68 
 
 
        *    Total 
 e)   Date of the transaction   12 March 2021 
 f)   Place of the              London Stock Exchange (XLON) 
       transaction 
 

Peter Speirs

Company Secretary, responsible for releasing this announcement

+44 (0) 20 7399 2760

15 March 2021

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBBGDXSDBDGBU

(END) Dow Jones Newswires

March 15, 2021 07:24 ET (11:24 GMT)

Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Feb 2024 a Mar 2024 Clicca qui per i Grafici di Hikma Pharmaceuticals
Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico
Da Mar 2023 a Mar 2024 Clicca qui per i Grafici di Hikma Pharmaceuticals